Time to abandon three-phase trials?
BMJ
.
2016 Feb 17:352:i764.
doi: 10.1136/bmj.i764.
Author
Andrew V Metcalfe
1
Affiliation
1
University of Adelaide, Adelaide, SA 5005, Australia andrew.metcalfe@adelaide.edu.au.
PMID:
26888378
DOI:
10.1136/bmj.i764
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials, Phase I as Topic*
Drug-Related Side Effects and Adverse Reactions*
Healthy Volunteers*
Humans
Risk Assessment*